ZOMIG Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zomig, and when can generic versions of Zomig launch?
Zomig is a drug marketed by Amneal, IPR, and Astrazeneca. and is included in three NDAs.
The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zomig
A generic version of ZOMIG was approved as zolmitriptan by GLENMARK GENERICS on May 14th, 2013.
Summary for ZOMIG
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 99 |
Patent Applications: | 4,317 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZOMIG |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ZOMIG |
What excipients (inactive ingredients) are in ZOMIG? | ZOMIG excipients list |
DailyMed Link: | ZOMIG at DailyMed |
Pharmacology for ZOMIG
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ZOMIG
Paragraph IV (Patent) Challenges for ZOMIG
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ZOMIG | Nasal Spray | zolmitriptan | 2.5 mg/spray | 021450 | 1 | 2016-06-09 |
ZOMIG | Nasal Spray | zolmitriptan | 5 mg/spray | 021450 | 1 | 2013-11-14 |
US Patents and Regulatory Information for ZOMIG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-003 | Sep 16, 2013 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-004 | Sep 30, 2003 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | ZOMIG-ZMT | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 021231-002 | Sep 17, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | ZOMIG-ZMT | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 021231-001 | Feb 13, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOMIG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-004 | Sep 30, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-004 | Sep 30, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-003 | Sep 16, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZOMIG
See the table below for patents covering ZOMIG around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovenia | 1237551 | ⤷ Try a Trial | |
Slovakia | 281621 | ⤷ Try a Trial | |
Canada | 2064815 | COMPOSES HETEROCYCLIQUES THERAPEUTIQUES (THERAPEUTIC HETEROCYCLIC COMPOUNDS) | ⤷ Try a Trial |
Denmark | 0486666 | ⤷ Try a Trial | |
Germany | 19775091 | ⤷ Try a Trial | |
Poland | 166800 | ⤷ Try a Trial | |
Norway | 322119 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZOMIG
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0486666 | 72/1997 | Austria | ⤷ Try a Trial | PRODUCT NAME: ZOLMITRIPTAN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ZULAESSIGEN SALZES; NAT. REGISTRATION NO/DATE: 1-22068, 1-22069 19970819; FIRST REGISTRATION: GB 12619/0116, 12619/0117 19970307 |
0486666 | SPC/GB97/089 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ZOLMITRIPTAN AND OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK 12619/0116 19970307 |
0486666 | C980001 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ZOLMITRIPTANUM, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AANVAARDBAAR ZOUT OF VAN EEN SOLVAAT; NAT. REGISTRATION NO/DATE: RVG 21079, RVG 21080 19970925; FIRST REGISTRATION: GB PL 12619/0116 19970307 |
0463756 | 300048 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ZOLMITRIPTANUM, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AANVAARDBAAR ZOUT OF VAN EEN SOLVAAT; NATL. REGISTRATION: RVG 21079 RVG 21080 19970925; FIRST REGISTRATION: PL 12619/0116 19970307 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |